BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26526176)

  • 1. Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist.
    Kan QE; Su Y; Yang H; Man H
    Int J Biol Macromol; 2016 Jan; 82():892-7. PubMed ID: 26526176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist.
    Cui H; Ma YZ; Wang Y; Song M; Zhang H
    Int J Biol Macromol; 2017 Feb; 95():1223-1227. PubMed ID: 27829125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal image anti-idiotypic antibody: A new strategy for the development a new category of prolactin receptor (PRLR) antagonist.
    Lan H; Hong P; Li R; L S; Anshan S; Li S; Zheng X
    Mol Immunol; 2017 Jul; 87():86-93. PubMed ID: 28412548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Novel, Anti-idiotypic Monoclonal Anti-prolactin Antibody That Mimics the Physiological Functions of Prolactin.
    Wang M; Zhang DC; Wang ST; Li ML
    Asian-Australas J Anim Sci; 2016 Apr; 29(4):571-9. PubMed ID: 26949959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
    J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
    Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
    Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
    Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal antibody against human prolactin receptors.
    Banerjee R; Ginsburg E; Vonderhaar BK
    Int J Cancer; 1993 Nov; 55(5):712-21. PubMed ID: 7503956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
    Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
    Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular signaling transduction pathways triggered by a well-known anti-GHR monoclonal antibody, Mab263, in vitro and in vivo.
    Lan H; Li W; Jiang H; Yang Y; Zheng X
    Int J Mol Sci; 2014 Nov; 15(11):20538-54. PubMed ID: 25391041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.
    Liu Y; Zhang Y; Jiang J; Lobie PE; Paulmurugan R; Langenheim JF; Chen WY; Zinn KR; Frank SJ
    Mol Endocrinol; 2016 May; 30(5):504-17. PubMed ID: 27003442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation and differential signalling of the growth hormone receptor induced by pGH or anti-idiotypic monoclonal antibodies in primary rat hepatocytes.
    Li W; Lan H; Liu H; Fu Z; Yang Y; Han W; Guo F; Liu Y; Zhang H; Liu J; Zheng X
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):51-9. PubMed ID: 23769824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2.
    Swaminathan G; Varghese B; Thangavel C; Carbone CJ; Plotnikov A; Kumar KG; Jablonski EM; Clevenger CV; Goffin V; Deng L; Frank SJ; Fuchs SY
    J Endocrinol; 2008 Feb; 196(2):R1-7. PubMed ID: 18252943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes.
    Clevenger CV; Medaglia MV
    Mol Endocrinol; 1994 Jun; 8(6):674-81. PubMed ID: 7935483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
    García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
    Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting.
    Buteau H; Pezet A; Ferrag F; Perrot-Applanat M; Kelly PA; Edery M
    Mol Endocrinol; 1998 Apr; 12(4):544-55. PubMed ID: 9544990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.
    Kline JB; Rycyzyn MA; Clevenger CV
    Mol Endocrinol; 2002 Oct; 16(10):2310-22. PubMed ID: 12351696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor.
    Langenheim JF; Chen WY
    J Recept Signal Transduct Res; 2009; 29(2):107-12. PubMed ID: 19519175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice.
    Otto C; Särnefält A; Ljungars A; Wolf S; Rohde-Schulz B; Fuchs I; Schkoldow J; Mattsson M; Vonk R; Harrenga A; Freiberg C
    Endocrinology; 2015 Nov; 156(11):4365-73. PubMed ID: 26284426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.